FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2056568565> ?p ?o ?g. }

• W2056568565 endingPage "2964" @default.
• W2056568565 startingPage "2962" @default.
• W2056568565 abstract "Mycophenolate mofetil (MMF) monotherapy has recently been proposed for liver transplant recipients with adverse events (nephrotoxicity, hypertension) related to calcineurin inhibitors. We analyzed the influence of MMF on the clinical course of recurrent hepatitis C. Among 1038 patients who underwent liver transplantation (OLT) from April 1986 to October 2006, we analyzed 48 adult recipients (4.6%) whose diagnosis was hepatitis C virus (HCV) cirrhosis and who were converted from calcineurin inhibitors to MMF monotherapy. The 36 men and 12 women, had a mean age at OLT of 52.9 ± 7.2 years; the time elapsed from OLT to the onset of MMF monotherapy was 72.5 ± 47.6 months (range = 11–210). The mean follow-up after monotherapy was 19 ± 16.1 months (range = 2–67). Indications for conversion were: chronic renal dysfunction with HCV in 45 patients; HCV recurrence in two; and hypertension plus HCV recurrence in one subject. When the indication was renal dysfunction (excluding three patients who underwent hemodialysis), the mean creatinine values decreased significantly from baseline to 6 months of monotherapy from 1.63 ± 0.61 mg/dL to 1.51 ± 0.78 mg/dL (P < .03). The creatinine clearance only improved significantly from the baseline value of 56.6 ± 16.8 mL/min to the value at 3 months of monotherapy—63.6 ± 18.4 mL/min (P < .001). At the last outpatient visit, creatinine and creatinine clearances had not changed significantly. The mean diastolic blood pressure did improve significantly at the end of the study. The mean glucose levels decreased but not significantly at the last outpatient visit. Liver function tests did not change significantly after conversion to MMF monotherapy. The acute rejection rate was 8.3%, and adverse events related to MMF monotherapy were present in 9 patients (18.7%). Conversion from calcineurin inhibitors to MMF monotherapy in patients who underwent OLT for HCV transiently improved renal function and hypertension. The acute rejection rate was low, and adverse events were usually well tolerated." @default.
• W2056568565 created "2016-06-24" @default.
• W2056568565 creator A5003895863 @default.
• W2056568565 creator A5018118284 @default.
• W2056568565 creator A5034905417 @default.
• W2056568565 creator A5050617243 @default.
• W2056568565 creator A5059809367 @default.
• W2056568565 creator A5061039664 @default.
• W2056568565 creator A5062816249 @default.
• W2056568565 creator A5076915973 @default.
• W2056568565 creator A5086859841 @default.
• W2056568565 creator A5050654176 @default.
• W2056568565 date "2008-11-01" @default.
• W2056568565 modified "2023-10-17" @default.
• W2056568565 title "Mycophenolate Mofetil Monotherapy in Patients Who Underwent Liver Transplantation for Hepatitis C Cirrhosis" @default.
• W2056568565 cites W1972054849 @default.
• W2056568565 cites W1997485357 @default.
• W2056568565 cites W2012093574 @default.
• W2056568565 cites W2024061812 @default.
• W2056568565 cites W2026049580 @default.
• W2056568565 cites W2034762297 @default.
• W2056568565 cites W2039396665 @default.
• W2056568565 cites W2040835239 @default.
• W2056568565 cites W2045137114 @default.
• W2056568565 cites W2049191601 @default.
• W2056568565 cites W2061417566 @default.
• W2056568565 cites W2090959382 @default.
• W2056568565 cites W2116618757 @default.
• W2056568565 cites W2128407483 @default.
• W2056568565 cites W2168638212 @default.
• W2056568565 cites W2171220237 @default.
• W2056568565 cites W2171777999 @default.
• W2056568565 cites W2333072798 @default.
• W2056568565 cites W2617325236 @default.
• W2056568565 doi "https://doi.org/10.1016/j.transproceed.2008.09.040" @default.
• W2056568565 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19010160" @default.
• W2056568565 hasPublicationYear "2008" @default.
• W2056568565 type Work @default.
• W2056568565 sameAs 2056568565 @default.
• W2056568565 citedByCount "7" @default.
• W2056568565 countsByYear W20565685652012 @default.
• W2056568565 countsByYear W20565685652018 @default.
• W2056568565 crossrefType "journal-article" @default.
• W2056568565 hasAuthorship W2056568565A5003895863 @default.
• W2056568565 hasAuthorship W2056568565A5018118284 @default.
• W2056568565 hasAuthorship W2056568565A5034905417 @default.
• W2056568565 hasAuthorship W2056568565A5050617243 @default.
• W2056568565 hasAuthorship W2056568565A5050654176 @default.
• W2056568565 hasAuthorship W2056568565A5059809367 @default.
• W2056568565 hasAuthorship W2056568565A5061039664 @default.
• W2056568565 hasAuthorship W2056568565A5062816249 @default.
• W2056568565 hasAuthorship W2056568565A5076915973 @default.
• W2056568565 hasAuthorship W2056568565A5086859841 @default.
• W2056568565 hasConcept C126189478 @default.
• W2056568565 hasConcept C126322002 @default.
• W2056568565 hasConcept C126894567 @default.
• W2056568565 hasConcept C128057223 @default.
• W2056568565 hasConcept C159641895 @default.
• W2056568565 hasConcept C197934379 @default.
• W2056568565 hasConcept C2776455275 @default.
• W2056568565 hasConcept C2776999253 @default.
• W2056568565 hasConcept C2777214474 @default.
• W2056568565 hasConcept C2778653478 @default.
• W2056568565 hasConcept C2779609443 @default.
• W2056568565 hasConcept C2780091579 @default.
• W2056568565 hasConcept C2780306776 @default.
• W2056568565 hasConcept C2909675724 @default.
• W2056568565 hasConcept C2911091166 @default.
• W2056568565 hasConcept C71924100 @default.
• W2056568565 hasConcept C90924648 @default.
• W2056568565 hasConceptScore W2056568565C126189478 @default.
• W2056568565 hasConceptScore W2056568565C126322002 @default.
• W2056568565 hasConceptScore W2056568565C126894567 @default.
• W2056568565 hasConceptScore W2056568565C128057223 @default.
• W2056568565 hasConceptScore W2056568565C159641895 @default.
• W2056568565 hasConceptScore W2056568565C197934379 @default.
• W2056568565 hasConceptScore W2056568565C2776455275 @default.
• W2056568565 hasConceptScore W2056568565C2776999253 @default.
• W2056568565 hasConceptScore W2056568565C2777214474 @default.
• W2056568565 hasConceptScore W2056568565C2778653478 @default.
• W2056568565 hasConceptScore W2056568565C2779609443 @default.
• W2056568565 hasConceptScore W2056568565C2780091579 @default.
• W2056568565 hasConceptScore W2056568565C2780306776 @default.
• W2056568565 hasConceptScore W2056568565C2909675724 @default.
• W2056568565 hasConceptScore W2056568565C2911091166 @default.
• W2056568565 hasConceptScore W2056568565C71924100 @default.
• W2056568565 hasConceptScore W2056568565C90924648 @default.
• W2056568565 hasIssue "9" @default.
• W2056568565 hasLocation W20565685651 @default.
• W2056568565 hasLocation W20565685652 @default.
• W2056568565 hasOpenAccess W2056568565 @default.
• W2056568565 hasPrimaryLocation W20565685651 @default.
• W2056568565 hasRelatedWork W174477127 @default.
• W2056568565 hasRelatedWork W2014603468 @default.
• W2056568565 hasRelatedWork W2037825761 @default.
• W2056568565 hasRelatedWork W2053110560 @default.
• W2056568565 hasRelatedWork W2060629978 @default.
• W2056568565 hasRelatedWork W2081280770 @default.

• next